Lutein
Lutein, licence 80122357: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Extra Strength Lutein, Extra Strength Lutein 25 mg, Extra Strength Lutein 25 mg with 5 mg Zeaxanthin, Lutein & Zeaxanthin, Lutein 25 mg, Lutein 25 mg with 5 mg Zeaxanthin, Lutein Formula, Lutein and Zeaxanthin, Lutein with Zeaxanthin
- Licence holder
- Vita Health Products Inc.
- NPN or DIN-HM
- 80122357
- Status
- Active licence
- Licence date
- 13 December 2022
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (3R,3'S)-b,b-carotène-3,3'-diol Source : Tagetes erecta - Petal | 2.5 mg | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 2.5 mg | Not calculated |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 25.0 mg | Not calculated |
Non-medicinal ingredients
Huile de tournesol, Rocou, Glycérine, Gélatine, Tocophérols, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 ans | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Source of/Provides (an) antioxidant(s) (for the maintenance of good health). Source of/Provides (an) antioxidant(s) for the maintenance of eye health. Helps to protect the eyes against (damaging) blue light (emitted by electronic devices). Helps to protect the eyes against (damaging) blue light (emitted by electronic devices) and oxidative damage. Helps to protect the eyes by filtering out (harmful) blue light (due to electronic devices). Helps to protect the eyes by reducing blue light exposure emitted from electronic devices. Helps to support eye health by filtering out (damaging/harmful) blue light. Helps improve macular pigment optical density, which helps protect the eyes (retina) by filtering out harmful blue light (emitted by electronic devices). Helps improve contrast sensitivity. Helps to improve glare recovery. Clinically proven to help improve macular pigment optical density which is an important factor for eye health. Helps to naturally protect(s)/defend(s) eyes from the harmful effects of blue light (emitted by electronic devices) by improving macular pigment optical density. Helps to maintain cognitive health. Source of/Provides antioxidants for the maintenance of eye and brain health. Helps improve visual acuity in persons with age-related macular degeneration. Helps to improve macular pigment optical density, which is associated with cognitive function. Source of/provides antioxidants for the maintenance of brain health. Helps to support/maintain cognitive function/performance. Helps to support visual memory. Helps support mental focus. Helps support sustained attention in older adults. Helps to improve/enhance visual performance (improved glare recovery and contrast sensitivity) during activities such as driving at night. Helps to protect the eyes against the harmful effects of long-term computer display blue-light exposure.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80122357
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.